Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of CSX-1004 [Phase 1]

View source ↗

Summary

Phase 1 study of CSX-1004 reports safety, tolerability, and pharmacokinetics in participants with opioid overdose or opioid use disorder; the trial status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose
• Opioid Use Disorder

Drugs mentioned

• CSX-1004

Snippet

Sponsor: Cessation Therapeutics, Inc. | Conditions: Opioid Overdose, Opioid Use Disorder | Phase 1 | Status: COMPLETED